PEG & ADCs
- Cleavable vs. Non-Cleavable Linkers in Antibody-Drug Conjugates
- A Novel Antibody Drug Conjugate Against Pancreatic Cancer
- ADCs, A Highly Targeted Drug Therapy For Cancer
- Progresses Of ADC Technology For Cancer Therapy
- Blockbuster Drugs Approved by the FDA in August 2020
- Anti-Cancer ADC Drugs: 3 Design Elements, 10 Approved ADCs, Multiple Clinical Trials
- The History Of ADC Drugs Development
- Innovative Linker Technology for Antibody Drug Conjugates (ADCs)
- FDA Approves Sacituzumab Govitecan for Triple-Negative Breast Cancer
- ADC Drugs to be Launched In 2020